Cargando…

Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity

BACKGROUND: Nanoparticles (NPs) incorporating drug formulations can be used to facilitate passage through biological barriers including the blood–brain barrier (BBB) and increase drug delivery and bioavailability. Hence, NP-based administration may enhance the efficiency of current antipsychotics. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugasi, L., Grinberg, I., Rudnick-Glick, S., Okun, E., Einat, H., Margel, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580026/ https://www.ncbi.nlm.nih.gov/pubmed/33087104 http://dx.doi.org/10.1186/s12951-020-00709-z

Ejemplares similares

Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone
por: Lugasi, Liroy, et al.
Publicado: (2020)

Engineering of NIR fluorescent PEGylated poly(RGD) proteinoid polymers and nanoparticles for drug delivery applications in chicken embryo and mouse models
por: Hadad, Elad, et al.
Publicado: (2020)

Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications
por: Hadad, Elad, et al.
Publicado: (2020)

Synthesis and Characterization of Poly(RGD) Proteinoid Polymers and NIR Fluorescent Nanoparticles of Optimal d,l-Configuration for Drug-Delivery Applications—In Vitro Study
por: Hadad, Elad, et al.
Publicado: (2020)

Engineering and use of proteinoid polymers and nanocapsules containing agrochemicals
por: Sasson, Elisheva, et al.
Publicado: (2020)

Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
por: Itzhaki, Ella, et al.
Publicado: (2021)

Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies
por: Itzhaki, Ella, et al.
Publicado: (2023)

Synthesis and characterization of bioactive conjugated near-infrared fluorescent proteinoid-poly(L-lactic acid) hollow nanoparticles for optical detection of colon cancer
por: Kolitz-Domb, Michal, et al.
Publicado: (2014)

Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model
por: Rudnick-Glick, S., et al.
Publicado: (2016)

Engineering of near infrared fluorescent proteinoid-poly(L-lactic acid) particles for in vivo colon cancer detection
por: Kolitz-Domb, Michal, et al.
Publicado: (2014)

Near IR fluorescent conjugated poly(ethylene glycol)bisphosphonate nanoparticles for in vivo bone targeting in a young mouse model
por: Rudnick-Glick, S., et al.
Publicado: (2015)

Engineering of a New Bisphosphonate Monomer and Nanoparticles of Narrow Size Distribution for Antibacterial Applications
por: Tal, Nimrod, et al.
Publicado: (2018)

Learning in ensembles of proteinoid microspheres
por: Mougkogiannis, Panagiotis, et al.
Publicado: (2023)

Proteinoid Microspheres as Protoneural Networks
por: Mougkogiannis, Panagiotis, et al.
Publicado: (2023)

Engineering of Durable Antifog Thin Coatings on Plastic Films by UV-Curing of Proteinoid Prepolymers with PEG-Diacrylate Monomers
por: Sason, Elisheva, et al.
Publicado: (2019)

Logical gates in ensembles of proteinoid microspheres
por: Mougkogiannis, Panagiotis, et al.
Publicado: (2023)

Low frequency electrical waves in ensembles of proteinoid microspheres
por: Mougkogiannis, Panagiotis, et al.
Publicado: (2023)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Liu-Seifert, Hong, et al.
Publicado: (2009)

The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
por: May, Meghan, et al.
Publicado: (2019)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Does risperidone seem safe in patients with antipsychotic-induced leukoneutropenia? Case report
por: Abid, W., et al.
Publicado: (2023)

Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies
por: Sbârcea, Laura, et al.
Publicado: (2020)

Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
por: O'Sullivan, David, et al.
Publicado: (2014)

STRUCTURE OF THE D(2) DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE
por: Wang, Sheng, et al.
Publicado: (2018)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Risperidone-Induced Tardive Akathisia: A Rare Antipsychotic Side Effect with Management Issues
por: Mishra, Biswa Ranjan, et al.
Publicado: (2019)

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021)

Enhancing the Antipsychotic Effect of Risperidone by Increasing Its Binding Affinity to Serotonin Receptor via Picric Acid: A Molecular Dynamics Simulation
por: Alhomrani, Majid, et al.
Publicado: (2022)

The encapsulation of an amphiphile into polystyrene microspheres of narrow size distribution
por: Pellach, Michal, et al.
Publicado: (2011)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo
por: Canfrán-Duque, Alberto, et al.
Publicado: (2021)

Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

Exposure to risperidone versus other antipsychotics and risk of osteoporosis‐related fractures: a population‐based study
por: Clapham, E., et al.
Publicado: (2019)

Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone
por: Zhang, Shuyao, et al.
Publicado: (2022)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lek5i22bdmhrbflreemqs78ckr